How I treat Waldenström macroglobulinemia

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1The genomic landscape of Waldenström macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis2013 · 483 citations
2. 2Lenalidomide is safe and active in <scp>W</scp>aldenström macroglobulinemia2015 · 26 citations
3. 3Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia2015 · 944 citations
4. 4Effective treatment of Bing‐Neel Syndrome with oral fludarabine: a case series of four consecutive patients2015 · 24 citations
5. 5Placebo-controlled trial of rituximab in IgM anti-myelin–associated glycoprotein neuropathy2013 · 206 citations